RecallDepth
Class I Ongoing

Ropivacaine Hydrochloride Injection, USP, 0.5%, 500 mg per 100 mL (5mg/mL), Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Mehsana, India, , Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807 NDC 70121-1734-1 (bag); NDC 70121-1734-3 (box)

This recall is currently active, issued May 14, 2025. It was issued by Amneal Pharmaceuticals, Llc.

Company
Amneal Pharmaceuticals, Llc
Recall Initiated
April 17, 2025
Posted
May 14, 2025
Recall Number
D-0402-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
62 (12x100mL) bags
Firm Location
Bridgewater, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter

Distribution

Nationwide in the US

Lot / Code Info

Lot #'s: AL240003, AL240004, Exp.: 01/31/2026

More recalls by Amneal Pharmaceuticals, Llc

View all recalls by this company →

Other recent Class I Drug recalls